Neurodegenerative disease profoundly affects structures and pathways responsible for memory, cognition, and higher-order ...

Alzheimer disease (AD) is the most common cause of dementia and one of the leading causes of death in adults age 65 y or ...

Amyloid PET has become a pivotal imaging biomarker for Alzheimer disease (AD), enabling in vivo detection and quantification of β-amyloid deposition. However, variability in quantitative measurements ...

The approval of disease-modifying antiamyloid therapies has expanded the clinical role of amyloid PET beyond diagnostic confirmation to include baseline characterization and longitudinal monitoring of ...

The growing demand for amyloid and tau PET imaging, driven by new dementia therapies and biomarker-based diagnosis, has increased the need for accessible PET brain imaging in outpatient neurology ...

Journal of Nuclear Medicine Technology February 2026, jnmt.125.271265; DOI: https://doi.org/10.2967/jnmt.125.271265 ...

Journal of Nuclear Medicine Technology February 2026, jnmt.125.271428; DOI: https://doi.org/10.2967/jnmt.125.271428 ...

Journal of Nuclear Medicine Technology January 2026, jnmt.125.271203; DOI: https://doi.org/10.2967/jnmt.125.271203 ...

Journal of Nuclear Medicine Technology January 2026, jnmt.125.270526; DOI: https://doi.org/10.2967/jnmt.125.270526 ...

Journal of Nuclear Medicine Technology December 2025, jnmt.125.270227; DOI: https://doi.org/10.2967/jnmt.125.270227 ...

Journal of Nuclear Medicine Technology December 2025, jnmt.125.270843; DOI: https://doi.org/10.2967/jnmt.125.270843 ...

Journal of Nuclear Medicine Technology December 2025, jnmt.125.271145; DOI: https://doi.org/10.2967/jnmt.125.271145 ...